Asthma control in Canada: no improvement since we last looked in 1999.
OBJECTIVE
To determine whether asthma control in Canada had improved since the last major survey in 1999 by exploring how well patients' asthma was controlled, how much they knew about asthma control, and how they used health care resources.


METHODS
National telephone survey of patients between April and August 2004.


METHODS
Canada.


METHODS
Eight hundred ninety-three adults 18 to 54 years old diagnosed with asthma more than 6 months before the survey.


METHODS
Patients' control of their asthma, patients' knowledge about asthma, the frequency and duration of periods of worsening asthma, and patients' use of health care resources to manage those periods.


RESULTS
In total, 26,210 households listed in a consumer database were contacted. Excluding ineligible households and households with a language barrier, a member of 13% of the households completed the 35-minute survey. Based on definitions in Canadian guidelines, 53% of patients had symptomatic uncontrolled asthma. In the previous year, almost all asthma patients had experienced worsening of symptoms that lasted on average 13.6 days for patients with uncontrolled asthma and 8.0 days for patients with controlled asthma (P < .02). Markedly more patients with uncontrolled asthma used health care resources for episodes of asthma than patients with controlled asthma did (72% vs 15% for urgent office visits, P < .01; 32% vs 3% for emergency department visits, P < .01; and 7% vs 0% for hospitalizations, P < .01) in the year before the survey. Patients were confused about the differences between reliever and controller medications. One third of patients claimed that no one had taught them about asthma medications, and one quarter said they had received no training on how to recognize the early signs of asthma worsening.


CONCLUSIONS
Asthma control and management remained suboptimal in Canada and relatively unchanged since the previous major survey in 1999.
McIvor
R Andrew
RA
McMaster University and Firestone Institute for Respiratory Health, St Joseph's Healthcare, 50 Charlton Ave E, Hamilton, ON L8N 4A6. amcivor@stjosham.on.ca
Boulet
Louis-Philippe
LP
FitzGerald
J Mark
JM
Zimmerman
Sabrina
S
Chapman
Kenneth R
KR
D000280:Administration, Inhalation; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy*; D002170:Canada; D016001:Confidence Intervals; D003695:Delivery of Health Care; D005194:Family Practice / Q000379:methods; D005260:Female; D006302:Health Services Research; D006760:Hospitalization / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance / Q000706:statistics & numerical data; D010353:Patient Education as Topic; D018570:Risk Assessment; D012720:Severity of Illness Index; D017678:Sex Distribution; D011795:Surveys and Questionnaires; D016019:Survival Analysis; D016896:Treatment Outcome
D018927:Anti-Asthmatic Agents